1d
GlobalData on MSNInceptor Bio doses first subject in trial of IB-T101 for renal cell carcinomaUS-based biotechnology company Inceptor Bio has dosed the first subject in the investigator-initiated trial of its lead ...
RESEARCH TRIANGLE PARK, NC, USA I5, 2025 I Inceptor Bio, a clinical-stage biotechnology company pioneering next-generation cell therapies, today ...
Pfizer placed a $6.7 billion bet on the outcome of two phase 3 trials of Arena Pharmaceuticals' etrasimod in ulcerative colitis (UC) when it acquired the company earlier this year, and the gamble ...
After hours: February 21 at 7:17:11 PM EST Loading Chart for MBIO ...
Feb. 21, 2025 — A hybrid microscope allows scientists to simultaneously image the full 3D orientation and position of an ensemble of molecules, such as labeled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results